Document Detail

Statins in Heart Failure.
MedLine Citation:
PMID:  23016898     Owner:  NLM     Status:  Publisher    
Clinical trials demonstrated that statin therapy is associated with a significant reduction in cardiovascular morbidity and mortality when used for either primary or secondary prevention of cardiovascular events. Several studies have shown that statins, having an important effect in the prevention of acute coronary syndromes, are also able to prevent heart failure (HF) in patients with coronary artery disease. This review summarizes the experimental and clinical evidence regarding the role of statins in the management of HF.
Michele Correale; Silvia Abruzzese; Carmen Adriana Greco; Morena Concilio; Matteo Di Biase; Natale Daniele Brunetti
Related Documents :
11605988 - Antioxidant properties of acetaminophen and cardioprotection.
8073948 - Therapeutic regulation of the complement system in acute injury states.
14965238 - Oxidative stress-induced ischemic heart disease: protection by antioxidants.
24742628 - Myocardial steatosis and necrosis in atria and ventricles of rats given pyruvate dehydr...
15148268 - Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-depende...
7021998 - Urokinase therapy of subclavian-axillary vein thrombosis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-20
Journal Detail:
Title:  Current vascular pharmacology     Volume:  -     ISSN:  1875-6212     ISO Abbreviation:  Curr Vasc Pharmacol     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101157208     Medline TA:  Curr Vasc Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Cardiology, University of Foggia, Viale Pinto 1, 71100 Foggia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anti-Fab Aptamers for Shielding Virus from Neutralizing Antibodies.
Next Document:  Lipid-lowering therapy in the diabetic foot: seeing the whole iceberg and not just the tip.